Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey
Clinical trial NCT05150496 · SUSPENDED
Trial details
- NCT number
- NCT05150496
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-15
- Primary completion
- 2023-01-15
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.